Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sutures of the Skull01:22

Sutures of the Skull

8.3K
The human skull is composed of several bones that come together to protect the brain and support the structures of the face. The junctions where these bones meet are called sutures.
Sutures are immobile joints between adjacent bones of the skull. The narrow gap between the bones is filled with dense, fibrous connective tissue that unites the bones. The long sutures located between the skull bones are not straight but instead follow irregular, tightly twisting paths. These twisting lines tightly...
8.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Decreased serotonin transporter activity in the mitral valve contributes to progression of degenerative mitral regurgitation.

Science translational medicine·2023
Same author

Cellular senescence is increased in airway smooth muscle cells of elderly persons with asthma.

American journal of physiology. Lung cellular and molecular physiology·2022
Same author

Cellular Senescence in Aging Lungs and Diseases.

Cells·2022
Same author

Photoencapsulated-BMP2 in visible light-cured thiol-acrylate hydrogels for craniofacial bone tissue engineering.

Regenerative medicine·2020
Same author

Photoencapsulated-mesenchymal stromal cells in biodegradable thiol-acrylate hydrogels enhance regeneration of craniofacial bone tissue defects.

Regenerative medicine·2020
Same journal

RETRACTED: Bakshi et al. Crocin Inhibits Angiogenesis and Metastasis in Colon Cancer via TNF-α/NF-kB/VEGF Pathways. <i>Cells</i> 2022, <i>11</i>, 1502.

Cells·2026
Same journal

Correction: Verde et al. Molecular Mechanisms of Protein Aggregation in ALS-FTD: Focus on TDP-43 and Cellular Protective Responses. <i>Cells</i> 2025, <i>14</i>, 680.

Cells·2026
Same journal

Inflammation in Cardiomyopathies: Cellular Mechanisms Across Cardiac Phenotype.

Cells·2026
Same journal

IL-4/IL-13-Driven Dysregulation of Epidermal Lipid Metabolism in Atopic Dermatitis: An Immunometabolic Link Between Type 2 Inflammation and Barrier Dysfunction.

Cells·2026
Same journal

Activity of DNA- and RNA-Guided Prokaryotic Argonautes in Human Mitochondria.

Cells·2026
Same journal

Placental Pathophysiology in Maternal Psychoactive Substance Use: Biological, Clinical, and Forensic Perspectives.

Cells·2026
See all related articles

Related Experiment Video

Updated: Oct 12, 2025

Author Spotlight: Development and Evaluation of a Standardized Rat Model for Calvarial Suture-Bony Composite Defects
04:17

Author Spotlight: Development and Evaluation of a Standardized Rat Model for Calvarial Suture-Bony Composite Defects

Published on: May 10, 2024

881

Craniofacial Bone Tissue Engineering: Current Approaches and Potential Therapy.

Arbi Aghali1,2

  • 1Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN 55905, USA.

Cells
|November 27, 2021
PubMed
Summary
This summary is machine-generated.

Megakaryocytes (MKs) show promise for regenerating critical-size cranial defects by enhancing bone formation and Mesenchymal Stromal Cell (MSC) survival. This offers a potential new therapy for craniofacial bone regeneration.

Keywords:
BMP-2MKsMSCsTPObiomaterialscraniofacial bone regenerationgrowth factorstissue engineering

More Related Videos

Author Spotlight: Insights into the Use of Apple-Derived Cellulose Scaffolds for Bone Tissue Engineering
09:49

Author Spotlight: Insights into the Use of Apple-Derived Cellulose Scaffolds for Bone Tissue Engineering

Published on: February 23, 2024

2.0K
Author Spotlight: Enhancing Bone Regeneration with Vascularized Artificial Cartilage Integration
06:05

Author Spotlight: Enhancing Bone Regeneration with Vascularized Artificial Cartilage Integration

Published on: July 14, 2023

1.2K

Related Experiment Videos

Last Updated: Oct 12, 2025

Author Spotlight: Development and Evaluation of a Standardized Rat Model for Calvarial Suture-Bony Composite Defects
04:17

Author Spotlight: Development and Evaluation of a Standardized Rat Model for Calvarial Suture-Bony Composite Defects

Published on: May 10, 2024

881
Author Spotlight: Insights into the Use of Apple-Derived Cellulose Scaffolds for Bone Tissue Engineering
09:49

Author Spotlight: Insights into the Use of Apple-Derived Cellulose Scaffolds for Bone Tissue Engineering

Published on: February 23, 2024

2.0K
Author Spotlight: Enhancing Bone Regeneration with Vascularized Artificial Cartilage Integration
06:05

Author Spotlight: Enhancing Bone Regeneration with Vascularized Artificial Cartilage Integration

Published on: July 14, 2023

1.2K

Area of Science:

  • Regenerative Medicine
  • Biomaterials Science
  • Craniofacial Surgery

Background:

  • Craniofacial bone defects arise from diverse causes, necessitating effective regeneration strategies.
  • Current tissue engineering approaches utilize biomaterials, stromal cells, and growth factors for bone repair.
  • Mesenchymal Stromal Cells (MSCs) and Bone Morphogenetic Protein-2 (BMP-2) are established in craniofacial defect regeneration.

Purpose of the Study:

  • To explore the potential of Megakaryocytes (MKs) as a novel therapeutic agent for craniofacial bone defect regeneration.
  • To investigate the effects of MKs on osteoblast proliferation and Mesenchymal Stromal Cell (MSC) survival and phenotype.

Main Methods:

  • Review of current literature on craniofacial bone defect regeneration.
  • Analysis of studies investigating Megakaryocyte (MK) induction by Thrombopoietin (TPO).
  • Evaluation of co-culture experiments assessing MKs' impact on MSCs.

Main Results:

  • Thrombopoietin (TPO)-induced Megakaryocytes (MKs) promote osteoblast proliferation in vitro and increase bone mass in vivo.
  • Mature MKs enhance Mesenchymal Stromal Cell (MSC) survival while preserving their essential characteristics.
  • MKs demonstrate potential for improving craniofacial bone regeneration outcomes.

Conclusions:

  • Megakaryocytes (MKs) represent a promising cell-based therapy for critical-size craniofacial bone defects.
  • MKs may offer a safe and effective alternative or adjunct to existing regenerative strategies.
  • Further research into MKs could advance craniofacial tissue engineering and bone repair.